Related Experiment Video
Updated: Mar 10, 2026
12:03
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
8.3K
Achieving HIV-1 Control through RNA-Directed Gene Regulation
Vera Klemm1, Jye Mitchell2, Christina Cortez-Jugo3,4
1Kirby Institute, The University of New South Wales, Sydney, NSW 2052, Australia. vklemm@kirby.unsw.edu.au.
Genes
|December 13, 2016
Summary
Gene therapies using RNA interference (RNAi) show promise for treating HIV-1 by silencing viral genes. This approach targets the latent HIV reservoir, a key barrier to a cure.
Area of Science:
- Immunology
- Molecular Biology
- Gene Therapy
Background:
- Combined anti-retroviral therapy (ART) has transformed HIV-1 infection into a manageable condition, but does not eliminate the virus.
- The persistent HIV-1 latent reservoir in resting CD4+ T cells remains a major obstacle to a cure, as it is unaffected by ART and can reactivate.
- Multi-drug resistance is another significant challenge in conventional HIV-1 treatment.
Approach:
- This review explores gene therapies utilizing RNA-directed gene regulation, specifically RNA interference (RNAi), as an alternative to traditional drug treatments.
- RNA interference, employing short interfering RNA (siRNA), induces gene silencing with high sequence specificity in conserved biological pathways.
- The focus is on developing RNAi technologies for HIV-1 gene therapy.
Key Points:
- RNAi offers a targeted approach to silence essential HIV-1 genes, potentially clearing the latent reservoir.
- Short interfering RNA (siRNA) leverages natural gene silencing pathways for high specificity.
- Current research is evaluating various RNAi technologies for their efficacy against HIV-1.
Conclusions:
- RNAi-based gene therapies represent a promising alternative strategy for achieving a functional HIV-1 cure.
- Overcoming challenges in delivery, stability, and specificity of RNAi therapeutics is crucial for clinical success.
- Further research and clinical trials are necessary to translate RNAi technology into effective HIV-1 treatments.
Related Concept Videos
01:29Viruses with RNA Genomes
1.2K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.2K
02:24Regulation of Expression Occurs at Multiple Steps
26.7K
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
26.7K
02:15Experimental RNAi
8.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K
01:23Regulation of Expression at Multiple Steps
1.5K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.5K
01:10Retrovirus Life Cycles
50.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.2K
01:23RNA Interference
28.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.4K